IL90058A0 - Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies - Google Patents

Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies

Info

Publication number
IL90058A0
IL90058A0 IL90058A IL9005889A IL90058A0 IL 90058 A0 IL90058 A0 IL 90058A0 IL 90058 A IL90058 A IL 90058A IL 9005889 A IL9005889 A IL 9005889A IL 90058 A0 IL90058 A0 IL 90058A0
Authority
IL
Israel
Prior art keywords
peptide
pharmaceutical compositions
directed against
hiv envelope
monoclonal antibodies
Prior art date
Application number
IL90058A
Other languages
English (en)
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/324,027 external-priority patent/US5562905A/en
Application filed by Du Pont filed Critical Du Pont
Publication of IL90058A0 publication Critical patent/IL90058A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL90058A 1988-04-26 1989-04-24 Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies IL90058A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18633388A 1988-04-26 1988-04-26
US07/324,027 US5562905A (en) 1988-04-26 1989-03-20 Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals

Publications (1)

Publication Number Publication Date
IL90058A0 true IL90058A0 (en) 1989-12-15

Family

ID=26881983

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90058A IL90058A0 (en) 1988-04-26 1989-04-24 Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies

Country Status (10)

Country Link
EP (1) EP0339504A3 (no)
JP (1) JPH02160800A (no)
AU (1) AU632475B2 (no)
DK (1) DK200189A (no)
FI (1) FI891957A (no)
HU (1) HUT51296A (no)
IL (1) IL90058A0 (no)
NO (1) NO891711L (no)
NZ (1) NZ228869A (no)
PT (1) PT90376B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69029937T2 (de) * 1989-04-25 1997-05-28 Tanox Biosystems Inc FÜr DIE CO4-BINDENDE DOMÄNE VON HIV SPEZIFISCHE ANTIKÖRPER
CA2058630A1 (en) * 1989-06-05 1990-12-06 Charles F. Scott, Jr. Human monoclonal antibodies to hiv-1 mn gp 120
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
ATE125157T1 (de) * 1990-04-03 1995-08-15 Genentech Inc Methoden und zusammensetzungen zur impfung gegen hiv.
WO1992000098A1 (en) * 1990-06-29 1992-01-09 Daniel Zagury Methods of inducing immune response to aids virus
US5712373A (en) * 1990-07-02 1998-01-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute HIV monoclonal antibody specific for the HTLV-IIImn gp120 envelope glycoprotein
JP2989862B2 (ja) * 1990-07-02 1999-12-13 財団法人化学及血清療法研究所 モノクローナル抗体
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
WO1992021377A1 (en) * 1991-06-03 1992-12-10 Syntello Inc. Peptides for use in induction of t cell activation against hiv-1
ATE173024T1 (de) * 1991-08-22 1998-11-15 Nissin Food Products Ltd In der therapie von einer hiv-1-infektion verwendbare monoklonale antikörper
US5665569A (en) * 1991-08-22 1997-09-09 Nissin Shokuhin Kabushiki Kaisha HIV immunotherapeutics
CA2124691A1 (en) * 1991-12-02 1993-06-10 Jagannadha K. Sastry Compositions for eliciting cytotoxic t-lymphocyte responses against viruses
CA2084180A1 (en) * 1991-12-11 1993-06-12 Paul P. Hung Expression of specific immunogens using viral antigens
JPH0748276A (ja) * 1992-03-26 1995-02-21 Inmeru:Kk Ｈｉｖ感染症予防ワクチンおよびその製造法
WO1993019775A1 (en) * 1992-03-31 1993-10-14 Medimmune, Inc. Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins
WO1994008618A1 (en) * 1992-10-13 1994-04-28 Children's Hospital Oral tolerance and immune suppression in the treatment of aids
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
AU681633B2 (en) * 1993-03-11 1997-09-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Anti-HIV monoclonal antibody
US6180134B1 (en) 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
AU700371B2 (en) 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
CA2178341A1 (en) * 1993-10-15 1995-04-20 Eva M. Rakowicz-Szulczynska Detection and treatment of breast and gynecological cancer
ZA975889B (en) * 1996-07-08 1998-02-23 Genentech Inc HIV envelope polypeptides and vaccine.
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
FR2874612A1 (fr) * 2004-08-27 2006-03-03 Commissariat Energie Atomique Epitotes t cd4+ du vih restreints a hla-dp4 et leurs applications
EP2778681A1 (en) * 2013-03-15 2014-09-17 Biomay Ag Method for diagnosing a viral infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2571968B1 (fr) * 1984-10-18 1989-03-17 Pasteur Institut Virus purifie des lymphadenopathies et du syndrome d'immuno-depression acquise et antigenes d'enveloppe de ce virus, procede d'obtention de ce virus et de ces antigenes d'enveloppe de ce virus, applications de ce virus ou de ces antigenes a la preparation de compositions immunogenes ou pour le diagnostic des susdites affections.
DE122005000039I1 (de) * 1984-10-18 2006-02-23 Pasteur Institut DNS-Fragmente des GAG-Gens von LAV
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc
EP0269712A4 (en) * 1986-06-12 1990-06-26 Biogen Nv PEPTIDES INVOLVED IN THE PATHOGENESIS OF A HIV TYPE INFECTION.
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
JP2569185B2 (ja) * 1988-01-26 1997-01-08 アメリカ合衆国 抗ｈｉｖ応答を喚起する合成抗原

Also Published As

Publication number Publication date
PT90376A (pt) 1989-11-10
PT90376B (pt) 1995-01-31
FI891957A (fi) 1989-10-27
DK200189A (da) 1989-10-27
EP0339504A3 (en) 1990-09-12
EP0339504A2 (en) 1989-11-02
JPH02160800A (ja) 1990-06-20
NO891711D0 (no) 1989-04-25
AU632475B2 (en) 1993-01-07
FI891957A0 (fi) 1989-04-25
DK200189D0 (da) 1989-04-25
NO891711L (no) 1989-10-27
AU3332089A (en) 1989-11-02
HUT51296A (en) 1990-04-28
NZ228869A (en) 1992-02-25

Similar Documents

Publication Publication Date Title
IL90058A0 (en) Hiv envelope peptide,vaccines containing it,monoclonal antibodies directed against said peptide and pharmaceutical compositions containing said antibodies
IL103612A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IL105541A0 (en) Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same
NZ230199A (en) Antibody drug conjugate, intermediates and pharmaceutical compositions
IL106600A (en) Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof
EP0570916A3 (en) Serum albumin, recombinant human, preparation process and pharmaceutical composition.
NZ213566A (en) Grf releasing peptides, and pharmaceutical compositions
IL101425A0 (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus,methods for their use and pharmaceutical compositions containing the same
NZ222981A (en) 2'-deoxy-2'2'-difluoronucleosides, antibody conjugates and pharmaceuticals containing the conjugates
IL98845A0 (en) Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
EP0631506A4 (en) VACCINES COMPRISING SELECTIVELY DEGLYCOSYLATED HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEINS.
IL89778A (en) Unsaturated n-benzopyranyllactams, their preparation and pharmaceutical compositions containing them
IL85885A0 (en) Cyclic peptides,their preparation and pharmaceutical compositions containing them
IL98769A (en) Synthetic peptides, mixtures thereof, methods utilizing the same for detecting hiv antibodies and pharmaceutical compositions containing the same
IL92268A0 (en) 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL85688A0 (en) Immunoglobulin conjugates,their preparation and pharmaceutical compositions containing them
IL77990A (en) Monoclonal anti-alpha-amylase antibody,process for obtaining the same and pharmaceutical compositions containing the same
IL86710A0 (en) Polypeptide receptor for interleukin-2,antibodies against this polypeptide and pharmaceutical compositions containing the same
IL96216A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
IL91402A0 (en) Aminomethyl peptides,their preparation and pharmaceutical compositions containing them
DE3264718D1 (en) Piperazinoquinazoline antihypertensives, processes for preparing them, pharmaceutical compositions containing them, and immunogenic protein conjugates formed from them
IL92441A0 (en) Imidazole containing peptides,their preparation and pharmaceutical compositions containing them
IL88743A0 (en) Soluble recombinant fcepsilon-receptor,its preparation and pharmaceutical compositions containing it
IL90044A0 (en) Imidazolylmethyl-cycloalkane(b)indolones,their preparation and pharmaceutical compositions containing them
NZ233255A (en) Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope